More News

21 Feb 2019 Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme
20 Feb 2019 Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
14 Feb 2019 AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma
14 Feb 2019 Abilita Bio and Amgen Enter Into a Multi-Target Collaboration
14 Feb 2019 Glenmark to spin off its innovation business into a new company in the US
14 Feb 2019 Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
12 Feb 2019 Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
12 Feb 2019 3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies
12 Feb 2019 AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
11 Feb 2019 Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
11 Feb 2019 UCB and Epilepsy Society announce pioneering UK Genomics R&D collaboration
11 Feb 2019 Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
07 Feb 2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
05 Feb 2019 Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech
05 Feb 2019 Merck and GSK Announce Global Alliance to Jointly Develop and Commercialize M7824, a Novel Immunotherapy with Potential in Multiple Difficult-to-Treat Cancers
05 Feb 2019 ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company
04 Feb 2019 argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology
01 Feb 2019 I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong
01 Feb 2019 Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
01 Feb 2019 Alexion and Caelum Biosciences Announce Collaboration to Develop Targeted Therapy for Light Chain (AL) Amyloidosis
01 Feb 2019 Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children
31 Jan 2019 Repare Therapeutics Announces a Strategic Partnership Agreement With ONO Pharmaceutical Co., Ltd. for Repare’s Polθ Inhibitor Program in Japan and Selected Territories in Asia
29 Jan 2019 Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
29 Jan 2019 Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinson’s Disease and Friedreich’s Ataxia
29 Jan 2019 FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up